Skip to main content

Mechanisms of gastric contrasted with intestinal damage by non-steroidal anti-inflammatory drugs

  • Chapter
Side-Effects of Anti-Inflammatory Drugs

Part of the book series: Inflammation and Drug Therapy Series ((IDTH,volume 2))

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) differ in the propensity to cause irritation, ulceration and haemorrhage in the various regions of the gastro intestinal (GI) tract. Some drugs such as aspirin and other salicylates cause damage principally in the stomach and duodenum1, 2. However, there is now increasing evidence from clinical reports in man that some other NSAIDs may, in addition to causing damage in these upper GI regions2, also cause ulceration and haemorrhage in the lower regions of the small intestine, caecum and colon3–6 (Table 1). In fact the problem was of such concern in the case of the osmotic slow-release formulation of indomethacin (Osmosin) and for indoprofen* (Flosint) as to necessitate their withdrawal recently. There has also been concern that some NSAIDs with potent actions as inhibitors of prostaglandin (PG) synthesis might exacerbate inflammatory bowel diseases (IBDs)5.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Rainsford, KD (1984) Aspirin and the salicylates, ( London: Butterworths ), 148

    Google Scholar 

  2. Rainsford, KD (1982) An analysis of the gastro-intestinal side-effects of non-steroidal anti-comparative studies in man and laboratory species. Rheumatol Int, 2, 1

    Article  PubMed  CAS  Google Scholar 

  3. Rainsford, KD (1983) Mechanisms of intestinal mucosal damage by non-steroidal anti-inflammatory drugs. In: New Trends in Pathophysiology and Therapy of the Large Bowel. Barbara, L, Mignioli, M and Phillips, SP (eds), ( Amsterdam: Elsevier ), p207

    Google Scholar 

  4. Day, TK (1983) Intestinal perforation associated with osmotic-slow release indomethacin capsules. Br Med. J, 287, 167

    Article  Google Scholar 

  5. Langman, MJS, Morgan, L and Worrall, A (1985) Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage. Br Med J, 290, 347

    Article  CAS  Google Scholar 

  6. Anonymous (1983) Flosint’s UK PL suspended. Scrip, No. 856, 1

    Google Scholar 

  7. Smith, GL, Goulbourn, RA, Burt, RAP and Chatfield, DH (1977) Preliminary studies of absorption and excretion of benoxaprofen in man. Br J Clin Pharmacol, 4, 585

    PubMed  CAS  Google Scholar 

  8. Halsey, JP and Cardoe, N (1982) Gastrointestinal haemorrhage and benoxaprofen. Br Med J, 284, 408

    Google Scholar 

  9. Rainsford, KD (1982) A comparison of the gastric ulcerogenic drugs in rats and pigs. Eur J Rheumatol Infl, 5, 148

    CAS  Google Scholar 

  10. Vrhovac, B (1984) Anti-inflammatory analgesics and drugs used in gout. In: Meyler’s Side Effects of Drugs, 10th edn. Dukes, MNG (ed), ( Amsterdam: Elsevier ), 151

    Google Scholar 

  11. Fok, KH, George, PJM, Vicary, FH (1985) Peptic ulcers induced by piroxicam. Br Med J, 290, 117

    Article  CAS  Google Scholar 

  12. Beeman, B (1985) Peptic ulcers induced by piroxicam. Br Med J, 290, 789

    Article  Google Scholar 

  13. Inman, WHW and Rawson, NSB (1985) Peptic ulcer and piroxicam. Br Med J, 290, 932

    Article  CAS  Google Scholar 

  14. Weber, JCP (1984) Epidemiology of adverse reactions to nonsteroidal anti-inflammatory drugs. In: Rainsford, KD and Velo, GP (eds), Side Effects of Anti-inflammatory/Analgesic Drugs. ( New York: Raven Press), pl

    Google Scholar 

  15. Brogden, RN, Heel, RC, Speight, TM and Avery, GS (1981) Piroxicam: a review of its pharmacological properties and therapeutic efficacy. Drugs, 22, 165

    Article  PubMed  CAS  Google Scholar 

  16. Richardson, CJ, Blocka, KLN, Ross, SG and Verbeeck, RK (1985) Effects of age and sex on piroxicam disposition. Clin Pharmacol Ther, 37, 13

    Article  PubMed  CAS  Google Scholar 

  17. Netter, P, Faure, G, Regent, MC, Procnal, JA and Levy, G (1985) Salicylate kinetics in old age. Clin Pharmacol Ther, 38, 6

    Article  PubMed  CAS  Google Scholar 

  18. Rainsford, KD and Fox, SA (1985) Fine structural damage to the intestinal mucosa induced by two non-steroidal anti-inflammatory drugs of varying potency as prostaglandin synthesis inhibitors. Agents and Actions, 16, 66

    Article  PubMed  CAS  Google Scholar 

  19. Rainsford, KD (1986) Intestinal ulceration by anti-inflammatory drugs in rodents: lesions induced by the anti-inflammatory drug Wy-41,770, a weak inhibitor of prostaglandin synthesis, contrasted with those from the potent prostaglandin inhibitor, indomethacin. (submitted for publication)

    Google Scholar 

  20. Satoh, H, Guth, PH and Grossman, MI (1983) Role of bacteria in gastric ulceration produced by indomethacin in the rat: cytoprotective action of antibiotics. Gastroenterology, 84, 483

    PubMed  CAS  Google Scholar 

  21. Rainsford, KD (1978) The effects of aspirin and other non-steroidal antiinflammatory/analgesic drugs on the gastro-intestinal mucus glycoprotein synthesis in vivo: relationship to ulcerogenic actions. Biochem Pharmacol, 27, 877

    Article  PubMed  CAS  Google Scholar 

  22. Shriver, DA, Dove, PA, White, CB, Sandor, A and Rosenthale, ME (1977) A profile of the gastrointestinal toxicity of aspirin, indomethacin, oxaproxin, phenylbutazone, and fentiazic in arthritic and Lewis normal rats. Toxicol Appl Pharmacol, 42, 75

    Article  PubMed  CAS  Google Scholar 

  23. Di Pasquale, G and Welaj, P (1973) Ulcerogenic potential of indomethacin in arthritic and non-arthritic rats. J Pharm Pharmacol, 25, 831

    Article  Google Scholar 

  24. Duggan, DE, Hooke, KF, Noll, RM and Kwan, KC (1975) Enterohepatic recirculation of indomethacin and its role in intestinal ulceration. Biochem Pharmacol, 25, 1749

    Article  Google Scholar 

  25. Menasse, R, Hedwall, PR, Kraetz, J, Pericin, C, Riesterer, L, Sallman, A, Ziel, R and Jaques, R (1978) Pharmacologic properties of diclofenac sodium and its metabolites. Scan J Rheumatol Suppl. 22, 5

    Google Scholar 

  26. Rainsford, KD (1975) A synergistic interaction between aspirin, or other non-steroidal anti-inflammatory drugs, and stress which produces severe gastric mucosal damage in rats and pigs. Agents and Actions, 5, 553

    Article  PubMed  CAS  Google Scholar 

  27. Rainsford, KD (1978) The role of aspirin and gastric ulceration. Some factors involved in the development of gastric mucosal damage induced by aspirin in rats exposed to various stress conditions. Am J Dig Dis, 23, 521

    Google Scholar 

  28. Rainsford, KD (1981) Comparison of the gastric ulcerogenic activity of new non-steroidal anti-inflammatory drugs in stressed rats. Br J Pharmacol, 73, 226 P

    Google Scholar 

  29. Deardon, JC and Nicholson, RM (1984) Correlation between gastric irritancy and anti-inflammatory activity of non-steroidal anti-inflammatory drugs. J Pharm Pharmacol, 36, 713

    Article  Google Scholar 

  30. Rainsford, KD (1985) Relations between gastric irritancy/ulcerogenicity and antioedemic activity of non-steroidal anti-inflammatory drugs. J Pharm Pharmacol, 37, 678

    Article  PubMed  CAS  Google Scholar 

  31. Rainsford, KD (1985) An economical and highly sensitive assay for the gastrotoxicity of anti-inflammatory drugs, and anti-ulcer agents, in cholinomimetically-sensitized mice. Dig Dis Sci, 30, A-32

    Google Scholar 

  32. Rainsford, KD (1986) Gastro-ulcerogenic actions of non-steroidal anti-inflammatory drugs in mice incorporating sensitized by cholinomimetic treatment and lesions quantified by visual image analysis. J Pharm Pharmacol, (In Press)

    Google Scholar 

  33. Rainsford, KD (1978) Structure-activity relationships of non-steroidal anti-inflammatory drugs 1. Gastric ulcerogenic activity. Agents and Actions, 8, 587

    Google Scholar 

  34. Whitehouse, MW and Rainsford, KD (1982) Comparison of the gastric ulcerogenic activities of different salicylates. In: Pfeiffer, CJ (ed), Drugs and Peptic Ulcer Disease, ( Boca Raton, CRC Press ), 127

    Google Scholar 

  35. Rainsford, KD and Whitehouse, MW (1980) Anti-inflammatory/anti-pyretic salicylic acid esters with low gastric ulcerogenic activity. Agents and Actions, 10, 451

    Article  PubMed  CAS  Google Scholar 

  36. Whitehouse, MW and Rainsford, KD (1980) Esterification of acidic anti-inflammatory drugs suppresses their gastrotoxicity without adversely affecting their anti-inflammatory activity in rats. J Pharm Pharmacol, 32, 795

    Article  PubMed  CAS  Google Scholar 

  37. Rainsford, KD, Schweitzer, A, Green, P, Whitehouse, MW and Brune, K (1980) Bio-distribution in rats of some salicylates with low gastric ulcerogenicity. Agents and Actions, 10, 457

    Article  PubMed  CAS  Google Scholar 

  38. Whitehouse, MW, Rainsford, KD, Ardlie, NG, Young IG and Brune, K (1976) Alternatives to aspirin from biological sources. In: Rainsford, KD, et al. (eds), Agents and Actions, Suppl. 1, ( Basel: Birkhauser ), p43

    Google Scholar 

  39. Rainsford, KD and Peskar, BM (1979) Relationship between gastric ulceration and mucosal prostaglandin concentrations following chronic oral administration of aspirin preparations to pigs. In: Brune, K and Baggiolini, M (eds), Arachidonic Acid Metabolism in Inflammation and Thrombosis. Agents and Actions Suppl. 4, ( Basel: Birkhauser ), p293

    Google Scholar 

  40. Whittle, BJR and Vane, JR (1984) A biochemical basis for the gastrointestinal toxicity of non-steroid antirheumatoid drugs. Arch Toxicol (Suppl.), 7, 315

    Article  CAS  Google Scholar 

  41. Konturek, SJ (1984) Actions of non-steroid anti-inflammatory compounds on gastric mucosal integrity and prostaglandin formation in healthy subjects and peptic ulcer in patients. In: Rainsford, KD and Velo, GP (eds), Side Effects of Anti-Inflanrtoatory/Analgesic Drugs. ( New York: Raven Press ), p19

    Google Scholar 

  42. Rainsford, KD and Willis, C (1982) Relationhsip of gastric mucosal damage induced in pigs by anti-inflammatory drugs to their effects on prostaglandin production. Dig Dis Sci, 27, 624

    Article  PubMed  CAS  Google Scholar 

  43. Ligumsky, M, Golanska, EM, Hansen, DG and Kauffman, GL, Jr (1983) Aspirin can inhibit gastric mucosal cyclo-oxygenase without causing lesions in rat. Gastroenterology, 84, 756

    PubMed  CAS  Google Scholar 

  44. Aehringhaus, U, Weiler, H, Peskar, BA and Peskar, BM (1984) Molecular mechanisms of the gastric toxicity of antirheumatic drugs. Arch Toxicol (Suppl.), 7, 323

    Article  CAS  Google Scholar 

  45. Rainsford, KD, Fox, SA and Osborne, DJ (1984) Comparative effects of some non-steroidal anti-inflammatory drugs on the ultrastructural integrity and prostaglandin levels in the rat gastric mucosa: relationship to drug uptake. Scand J Gastroenterol, 19 (Suppl. 10), 55

    CAS  Google Scholar 

  46. Rainsford, KD (1986) Studies on the comparative gastro-intestinal ul- cerogenicity of non-steroidal anti-inflammatory drugs: studies with oxaprozin. (In preparation)

    Google Scholar 

  47. Rainsford, KD (1985) Preliminary investigations on the pharmacological con- trol of catabolin-induced cartilage destruction in vitro. Agents and Actions, 16, 55

    Article  PubMed  CAS  Google Scholar 

  48. Gilman, SC, Carlson, RP, Chang, J and Lewis, AJ (1985) The anti-inflammatory activity of the immunomodulator Wy-18,251 (3-(p-chlorophenyl)thiazolo[3,2a]-benzimidazole-2-acetic acid). Agents and Actions, 17, 53

    Article  PubMed  CAS  Google Scholar 

  49. Lanza, FL, Umbenhauer, ER, Nelson, RS, Rack, MF, Daurio, CP and White, LA (1982) A double blind randomized placebo-controlled gastroscopic study to compare the effects of indomethacin capsules and indomethacin suppositories on the gastric mucosa of human volunteers. J Rheumatol, 9, 415

    PubMed  CAS  Google Scholar 

  50. Abdel-Gagil, AAM and Marshall, PB (1968) Phenylbutazone and histamine forma- tion in rat glandular stomach: its relationship to gastric ulceration. Br J Pharmacol Chemother, 33, 1

    Google Scholar 

  51. Whittle, BJR (1981) Temporal relationship between cyclo-oxygenase inhibi- tion, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology, 80, 94

    PubMed  CAS  Google Scholar 

  52. Rainsford, KD (1978) Comparative studies on gastric ulcerogenesis by non- steroid anti-inflammatory drugs: effects of fenclofenac. Proc Roy Soc Med, 70, (Suppl. 6), 4

    Google Scholar 

  53. Del Soldato, P, Meli, A and Volterra, G (1979) Influence of fasting and cimetidine on the relationship between ulcerogenic and anti-inflammatory properties of indomethacin. Br J Pharmacol, 67, 33

    PubMed  Google Scholar 

  54. Benoni, G, Cuzzolin, L, Raimondi, MG and Velo, GP (1984) Indomethacin- induced intestinal lesions and fecal flora. In: Rainsford, KD and Velo, GP (eds), Side Effects of Anti-Inflammatory/Analgesic Drugs, ( New York: Raven Press ), 103

    Google Scholar 

  55. Elegbe, RA (1974) Prevention by two anticholinergic drugs of indomethacin- induced gastric mucosal ulceration in rats. Isr J Med Sci, 10, 1451

    PubMed  CAS  Google Scholar 

  56. Mozsik, G, Lovasz, L, Kutor, G, Nagy, L and Tarnok, F (1980) Experimental evidence for cytoprotective effect of atropine on the rat gastric mucosa. Acta Med Acad Sci Hung, 37, 401

    PubMed  CAS  Google Scholar 

  57. Konturek, SJ, Brzozowski, T, Radecki, T and Piastucki, I (1982) Gastric cytoprotection by pirenzepine. Role of endogenous prostaglandins. Scand J Gastroenterol, ( Suppl. ), 72, 255

    Google Scholar 

  58. Semple, PF and Russell, RI (1975) Role of bile acids in the pathogenesis of aspirin-induced gastric mucosal haemorrhage in rats. Gastroenterology, 68, 67

    PubMed  CAS  Google Scholar 

  59. Whittle, BJR (1983) The potentiation of taurocholate-induced rat gastric erosions following parenteral administration of cyclo-oxygenase inhibitors. Br J Pharmacol, 80, 545

    PubMed  CAS  Google Scholar 

  60. Mersereau, WA and Hinchey, EJ (1982) Prevention of phenylbutazone ulcer in the rat by glucose: role of a glycoprivic receptor system. Am J Physiol, 242, G429

    PubMed  CAS  Google Scholar 

  61. Rainsford, KD (1975) The bichemical pathology of aspirin-induced gastric damage. Agents and Actions, 5, 326

    Article  PubMed  CAS  Google Scholar 

  62. Tesler, MA and Lim, ES (1981) Protection of gastric mucosa by sucralfate from aspirin-induced erosions. J Clin Gastroenterol, 3 (Suppl. 3), 175

    PubMed  CAS  Google Scholar 

  63. Anderson, KW (1965) Further studies on aspirin-induced gastric lesions in the guinea-pig. Arch Int Pharmacodyn, 157, 181

    PubMed  CAS  Google Scholar 

  64. Kohut, A and Nicak, A (1974) Effect of guanethidine-induced sympathectomy on the ulcerogenic effect of phenylbutazone in rats of different ages. Cesk Gastroenterol Vyz, 28, 529

    PubMed  CAS  Google Scholar 

  65. Robert, A (1981) Current history of cytoprotection. Prostaglandins (Suppl.), 21, 89

    CAS  Google Scholar 

  66. Johansson, C, Kollberg, B, Nordemar, R, Samuelson, K and Bergstrom, S (1980) Protective effect of prostaglandin E2 in the gastrointestinal tract during indomethacin treatment of rheumatic diseases. Gastroenterology, 78, 479

    PubMed  CAS  Google Scholar 

  67. Cohen, MM and Clark, L (1983) Preventing acetylsalicylic acid damage to human gastric mucosa by use of prostaglandin E2. Can.J Surg, 26, 116

    PubMed  CAS  Google Scholar 

  68. Miller, IA (1983) Protective effect of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms. Am J Physiol, 245, G601

    PubMed  CAS  Google Scholar 

  69. Parmar, NS and Hennings, G (1983) The effect of 3-methoxy-5,7,3’,4’tetrahydroxyflavin on the restraint-induced gastric ulceration augmented by aspirin, a gastric mucosal barrier breaker. Res Commun Chem Path Pharmacol, 41, 337

    CAS  Google Scholar 

  70. Davenport, HW (1967) Salicylate damage to the gastric mucosal barrier. N Engl J Med, 276, 1307

    Article  PubMed  CAS  Google Scholar 

  71. Lin, T-M, Warrick, MW, Evans, DC and Nash, JF (1975) Action of anti-inflammatory agents, acetylsalicylic acid, indomethacin and fenoprofen on the gastric mucosa of dogs. Res Commun Chem Path Pharmacol, 11, 1

    CAS  Google Scholar 

  72. Vottera, G, Del Soldato, P and Weli, A (1978) Indomethacin: Relationship between ulcerogenic and anti-inflammatory properties. 1. Effects of an intestinal lesion-preventing fat free diet on anti-edema and anti-granuloma properties of indomethacin in the rat. Proc Soc Exp Biol Med, 157, 615

    Google Scholar 

  73. Takagi, K and Kawashima, T (1969) Effects of some anti-inflammatory drugs on capillary permeability in the rat. Jap J Pharmacol, 19, 431

    Article  PubMed  CAS  Google Scholar 

  74. Hills, BA, Butler, BD and Lichtenberger, LM (1983) Gastric mucosal barrier: Hydrophobic lining to the lumen of the stomach. Am J Physiol, 24, G561

    Google Scholar 

  75. Lichtenberger, LM, Richards, JE and Hills, BA (1985) Effect of 16,16dimethyl prostaglandin E2 on the surface hydrophobicity of aspirin-treated canine gastric mucosa. Gastroenterology, 88, 308

    PubMed  CAS  Google Scholar 

  76. Rees, WDW, Gibbons, LC and Turnberg, LA (1983) Effects of non-steroidal anti-inflammatory drugs and prostaglandins on alkali secretion by rabbit gastric fundus in vitro. Gut, 24, 784

    Article  PubMed  CAS  Google Scholar 

  77. Allen, A and Garner, A (1980) Mucus and bicarbonate secretion in the stomach and their possible role in mucosal protection. Gut, 21, 249

    Article  PubMed  CAS  Google Scholar 

  78. Johnson, LR and Overholt, BF (1967) Release of histamine into gastric venous blood following injury by acetic or salicylic acid. Gastroenterology, 52, 505

    PubMed  CAS  Google Scholar 

  79. Nagamachi, Y (1977) Significance of gastric mucosal pepsinogen and plasma corticosteroid levels in the course of cincophen ulceration. Gastroenterologia Jap, 12, 13

    CAS  Google Scholar 

  80. Jorgensen, TG, Weis-Fogh, US and Olesen, HP (1976) Influence of acetylsalicylic acid (aspirin) on gastric mucosal content of energy-rich phosphate bonds. Scand J Clin Lab Invest, 36, 771

    Article  PubMed  CAS  Google Scholar 

  81. Rainsford, KD and Whitehouse, MW (1980) Biochemical gastro-protection from acute ulceration induced by aspirin and related drugs. Biochem Pharmacol, 29, 1281

    Article  PubMed  CAS  Google Scholar 

  82. Karppanen, H and Puurunen, J (1974) Phosphodiesterase inhibition by indomethacin and ethanol in the gastric mucosa of the guinea pig. Acta Pharmacol Toxicol, 35 (Suppl. 1), 36

    Google Scholar 

  83. Mangla, JC, Kim, YM and Rubulis, AA (1974) Adenyl cyclase stimulation by aspirin in rat gastric mucosa. Nature, 250, 61

    Article  PubMed  CAS  Google Scholar 

  84. Silvola, J, Kangasho, M, Tokola, 0 and Vapaatalo, H (1982) Effects of non- steroidal anti-inflammatory drugs on rat gastric mucosal phosphodiesterase activity. Agents and Actions, 12, 517

    Google Scholar 

  85. Rainsford, KD, Watkins, J and Smith, MJH (1968) Aspirin and mucus. J Pharm Pharmacol, 20, 941

    Article  PubMed  CAS  Google Scholar 

  86. Sarosiek, J, Slomiany, BL, Swierczek, J, Slomiany, A, Jozwiak, Z and Konturek, SJ (1984) Effect of acetylsalicylic acid on the constituents of the gastric mucosal barrier. Scand J Gastroenterol, 19, 150

    PubMed  CAS  Google Scholar 

  87. Turner, NC, Martin, GP and Marriott, C (1985) The influence of native gastric mucus gel on hydrogen ion diffusion: the effect of potentially ulcerogenic agents. J Pharm Pharmacol, 37, 776

    Article  PubMed  CAS  Google Scholar 

  88. Rainsford, KD (1982) Effects of anti-inflammatory drugs on mucus production: Relationship to ulcerogenesis. In: Pfeiffer, CH (ed), Drugs and Peptic Ulcer, vol. 2, ( Boca Raton, FL: CRC Press ), p227

    Google Scholar 

  89. Croft, DN (1963) Aspirin and the exfoliation of gastric epithelial cells. Cytological and biochemical observations. Br Med J, 2, 897

    Google Scholar 

  90. Konturek, SJ, Kwiecien, N, Obtulowicz, W, Zmuda, A, Polanski, M, Kopp, B, Sito, E and Oleksy, J (1983) The use of carprofen, a non-steroidal anti-inflammatory agent, in peptic ulcer diseases. Hepato-gastroenterology, 30, 261

    PubMed  CAS  Google Scholar 

  91. Walker, R and Wilson, KA (1979) A novel method for the detection of drug in- duced gastro-intestinal irritancy. J Pharm Pharmacol, 31 (Suppl.), 13 P

    Article  Google Scholar 

  92. Rainsford, KD (1975) Electronmicroscopic observations on the effects of aspirin and aspirin-bicarbonate mixtures on the development of gastric mucosal damage in the rat. Gut, 16, 514

    Article  PubMed  CAS  Google Scholar 

  93. Rainsford, KD, Fox, SA and Obsborne, DJ (1985) Relationship between drug ab- sorption, inhibition of cyclooxygenase and lipoxygenase pathways and the development of gastric mucosal damage by non-steroidal anti-inflammatory drugs in rats and pigs. In: Bailey, JM (ed.), Prostaglandins, Leukotrienes and Lipoxins, ( New York: Plenum )

    Google Scholar 

  94. Harding, RK and Morris, GP (1976) Pathological effects of aspirin and of haemorrhagic shock on the gastric mucosa of the rat. In: Scanning Electron Microscopy/1976 (Part V ), ( Chicago, IL: ITT Research Institute ), p253

    Google Scholar 

  95. Robins, PG (1980) Ultrastructural observations on the pathogenesis of aspirin-induced gastric erosions. Br J Exp Pathol, 61, 497

    PubMed  CAS  Google Scholar 

  96. Rainsford, KD, Willis, CM, Walker, SA and Robins, PG (1982) Electron micro- scopic observations comparing the gastric mucosal damage induced in rats and pigs by benoxaprofen and aspirin, reflecting their differing actions as prostaglandin-synthesis-inhibitors. Br J Exp Pathol, 63, 25

    PubMed  CAS  Google Scholar 

  97. Kauffman, GL, Aures, D and Grossman, MI (1979) Indomethacin decreases basal gastric mucosal blood flow. Gastroenterology, 76, 1165

    Google Scholar 

  98. Rainsford, KD (1984) The mechanisms of gastrointestinal ulceration by non-steroidal anti-inflammatory drugs. In: Rainsford, KD and Velo, GP (eds), Side Effects of Anti-inflammatory/Analgesic Drugs, ( New York: Raven Press ), 51

    Google Scholar 

  99. Krupinska, J, Sobanski, H, Piotrowicz, J, Cebo, B and Mazur, J (1980) Antioxidants as agents reducing the toxicity of indomethacin. Acta Biol Med Ger, 39, 717

    PubMed  CAS  Google Scholar 

  100. van Kolfschoten, AA, Hagelin, F and van Noordwijk, J (1984) Butyl hydroxy toluene antagonizes the gastric toxicity but not the pharmacological activity of acetylsalicylic acid in rats. Naunyn-Schmiedeberg’s Arch Pharmacol, 325, 283

    Article  PubMed  Google Scholar 

  101. Himal, HS, Greenberg, L, Boutros and Waldron-Edward, D (1981) Effect of aspirin on ionic movement and acid hydrolase activity of explants of canine antral and duodenal mucosae. Gastroenterology, 69, 439

    Google Scholar 

  102. Szabo, S, Trier, JS and Frankel, PW (1981) Sulfhydryl compounds may mediate gastric cytoprotection. Science, 214, 200

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 MTP Press Limited

About this chapter

Cite this chapter

Rainsford, K.D. (1987). Mechanisms of gastric contrasted with intestinal damage by non-steroidal anti-inflammatory drugs. In: Rainsford, K.D., Velo, G.P. (eds) Side-Effects of Anti-Inflammatory Drugs. Inflammation and Drug Therapy Series, vol 2. Springer, Dordrecht. https://doi.org/10.1007/978-94-010-9775-8_1

Download citation

  • DOI: https://doi.org/10.1007/978-94-010-9775-8_1

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-9777-2

  • Online ISBN: 978-94-010-9775-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics